ACA 2020 Expert consensus: Novel therapies for cardiovascular risk reduction in patients with type 2 diabetes
6 Aug, 2020 | 02:39h | UTCCommentary: Cardiology Group Recommends Diabetes Drugs for CV Prevention – NEJM Journal Watch
Commentary: Cardiology Group Recommends Diabetes Drugs for CV Prevention – NEJM Journal Watch